Beiyuan Hu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Extracellular vesicles in disease
- RNA modifications and cancer
- Circular RNAs in diseases
Papers in
-
- Cancer, Hypoxia, and Metabolism 3
- Cancer, Lipids, and Metabolism 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
Beiyuan Hu
19 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Cancer Research 613
- Molecular Biology 883
- Oncology 330
- Hepatology 76
- Immunology 178
Countries citing papers authored by Beiyuan Hu
This map shows the geographic impact of Beiyuan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beiyuan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beiyuan Hu more than expected).
Fields of papers citing papers by Beiyuan Hu
This network shows the impact of papers produced by Beiyuan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beiyuan Hu. The network helps show where Beiyuan Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Beiyuan Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 20 | |
| 3 | 2024 | 14 | |
| 4 | 2023 | 35 | |
| 5 | 2022 | 104 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 51 | |
| 11 | 2021 | 2 | |
| 12 | The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives Hit paper breakdown → | 2021 | 220 |
| 13 | 2021 | 88 | |
| 14 | Isolation and characterization of exosomes for cancer research Hit paper breakdown → | 2020 | 376 |
| 15 | 2020 | 22 | |
| 16 | 2020 | 90 | |
| 17 | 2020 | 57 | |
| 18 | 2019 | 118 | |
| 19 | 2019 | 71 | |
| 20 | 2018 | 10 |
About Beiyuan Hu
Beiyuan Hu is a scholar working on Cancer Research, Hepatology, Oncology, Physiology and Molecular Biology, having authored 20 papers that have together received 1.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Extracellular vesicles in disease (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Cells and Metastasis (3 papers), RNA modifications and cancer (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (613 citations), Molecular Biology (883 citations), Oncology (330 citations), Hepatology (76 citations) and Immunology (178 citations). Beiyuan Hu has collaborated with scholars based in China, Germany and Hong Kong. Frequent co-authors include Qiongzhu Dong, Lun–Xiu Qin, Yan Zheng, Le Zhu, Xiaotian Shen, Chaoqun Wang, Yan Fu, Tiantian Zou, Hu‐Liang Jia and Haoting Sun. Their work appears in journals such as Signal Transduction and Targeted Therapy, iScience, British Journal of Cancer, Cancer Biology and Medicine and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.